Rieneke van de Ven

1.7k citations

61 papers · 1.4k indexed · h-index 23

Immunology top 5%
- Immunotherapy and Immune Responses 40
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 11
Oncology top 5%
- Cancer Immunotherapy and Biomarkers 24
- CAR-T cell therapy research 13
- Drug Transport and Resistance Mechanisms 5
Cancer Research
Molecular Biology
Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 6
Genetics
- Virus-based gene therapy research 7

Co-authors: Tanja D. de Gruijl Rik J. Scheper George L. Scheffer Jelle J. Lindenberg Gerrit Jansen Dinja Oosterhoff Yvette van Kooyk Dorian A. Stolk
Cited by: Immunology Oncology Cancer Research
Journals: Nature Communications (1 paper)SHILAP Revista de lepidopterología (2 papers)Blood (3 papers)
Partner nations: Netherlands United States France

In The Last Decade

Rieneke van de Ven

61 papers receiving 1.4k citations

Peers

Countries citing papers authored by Rieneke van de Ven

Since Specialization

Citations

This map shows the geographic impact of Rieneke van de Ven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rieneke van de Ven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rieneke van de Ven more than expected).

Fields of papers citing papers by Rieneke van de Ven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rieneke van de Ven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rieneke van de Ven. The network helps show where Rieneke van de Ven may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rieneke van de Ven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rieneke van de Ven Line = papers co-authored together Rieneke van de Ven links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immune cell topography of head and neck cancer Journal for ImmunoTherapy of Cancer ·Tara Muijlwijk,Dennis N L M Nijenhuis,Sonja H. Ganzevles,Fatima Ekhlas,Carmen Ballesteros‐Merino,Laura A. N. Peferoen,Elisabeth Bloemena,Bernard A. Fox,Jos B. Poell,C. René Leemans,Ruud H. Brakenhoff,Rieneke van de Ven	2024	5
2	Secretome and immune cell attraction analysis of head and neck cancers Cancer Immunology Immunotherapy ·Tara Muijlwijk,Niels E. Wondergem,Fatima Ekhlas,Naomi Remkes,Dennis N. L. M. Nijenhuis,L C Fritz,Sonja H. Ganzevles,Iris H.C. Miedema,C. René Leemans,Jos B. Poell,Ruud H. Brakenhoff,Rieneke van de Ven	2024	4
3	Hallmarks of a genomically distinct subclass of head and neck cancer Nature Communications ·Tara Muijlwijk,Irene H. Nauta,Anabel van der Lee,K Grünewald,Arjen Brink,Sonja H. Ganzevles,Robert J. Baatenburg de Jong,Lilit Atanesyan,Suvi Savola,Mark A. van de Wiel,Laura A. N. Peferoen,Elisabeth Bloemena,Rieneke van de Ven,C. René Leemans,Jos B. Poell,Ruud H. Brakenhoff	2024	7
4	Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring Frontiers in Immunology ·Julie Berthe,Pawan Poudel,Felix J. Segerer,Emily C. Jennings,Felicia Ng,Michael Surace,Alma Andoni,Marco Testori,Megha Saraiya,Miljenka Vuko,Harald Hessel,Mari Heininen‐Brown,Jorge Blando,Emma V. Jones,Sophie E. Willis,Jérôme Galon,Rieneke van de Ven,Tanja D. de Gruijl,Helen K. Angell	2024	2
5	An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy Molecular Cancer Therapeutics ·Jantine E. Bakema,Marijke Stigter‐van Walsum,Jeffrey R. Harris,Sonja H. Ganzevles,Anantharaman Muthuswamy,Mischa Houtkamp,Theo S. Plantinga,Elisabeth Bloemena,Ruud H. Brakenhoff,Esther C.W. Breij,Rieneke van de Ven	2023	5
6	A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors Cancer Immunology Research ·Lisa A. King,Elisa C. Toffoli,Myrthe Veth,Victoria Iglesias‐Guimarais,Manon C. Slot,Derk Amsen,Rieneke van de Ven,Sarah Derks,Marieke F. Fransen,Jurriaan B. Tuynman,Thilo Riedl,Rob C. Roovers,Anton E.P. Adang,Jurjen M. Ruben,Paul W.H.I. Parren,Tanja D. de Gruijl,Hans van Vliet	2023	21
7	Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche Cell Reports ·Kevin Kos,Muhammad Assad Aslam,Rieneke van de Ven,Max D. Wellenstein,Wietske Pieters,Antoinette van Weverwijk,Danique E. M. Duits,Kim van Pul,Cheei‐Sing Hau,Kim Vrijland,Daphne Kaldenbach,Elisabeth A.M. Raeven,Sergio A. Quezada,Rudi Beyaert,Heinz Jacobs,Tanja D. de Gruijl,Karin E. de Visser	2022	39
8	NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models International Journal of Molecular Sciences ·Mandy Gruijs,Sonja H. Ganzevles,Marijke Stigter‐van Walsum,Richard van der Mast,Monique M. van Ostaijen-ten Dam,Cornelis W. Tuk,Marco W. Schilham,C. René Leemans,Ruud H. Brakenhoff,Marjolein van Egmond,Rieneke van de Ven,Jantine E. Bakema	2021	5
9	At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma SHILAP Revista de lepidopterología ·Niels E. Wondergem,Dennis N. L. M. Nijenhuis,Jos B. Poell,C. René Leemans,Ruud H. Brakenhoff,Rieneke van de Ven	2021	6
10	Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy Frontiers in Immunology ·Kim M. van Pul,Marieke F. Fransen,Rieneke van de Ven,Tanja D. de Gruijl	2021	71
11	A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies Cancer Immunology Research ·Iris de Weerdt,Roeland Lameris,George L. Scheffer,Jana Vree,Renate de Boer,Anita G.M. Stam,Rieneke van de Ven,Mark‐David Levin,Steven T. Pals,Rob C. Roovers,Paul W.H.I. Parren,Tanja D. de Gruijl,Arnon P. Kater,Hans van Vliet	2020	32
12	Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses Frontiers in Immunology ·Dorian A. Stolk,Aram de Haas,Jana Vree,Sanne Duinkerken,Joyce Lübbers,Rieneke van de Ven,Martino Ambrosini,Hakan Kalay,Sven C. M. Bruijns,Hans van Vliet,Tanja D. de Gruijl,Yvette van Kooyk	2020	33
13	The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites Current Oncology Reports ·Niels E. Wondergem,Irene H. Nauta,Tara Muijlwijk,C. René Leemans,Rieneke van de Ven	2020	62
14	Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma Cancer Research ·Jason R. Baird,R. Bryan Bell,Victoria Troesch,David J. Friedman,Shelly Bambina,Gwen Kramer,Tiffany C. Blair,Terry R. Medler,Yaping Wu,Zhaoyu Sun,Tanja D. de Gruijl,Rieneke van de Ven,Rom S. Leidner,Marka R. Crittenden,Michael J. Gough	2018	54
15	Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence Cancer Immunology Research ·Mari F.C.M. van den Hout,Bas D. Koster,Berbel J.R. Sluijter,Barbara G. Molenkamp,Rieneke van de Ven,Alfons J.M. van den Eertwegh,Rik J. Scheper,Paul A.M. van Leeuwen,M. Petrousjka van den Tol,Tanja D. de Gruijl	2017	37
16	Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation Cancer Immunology Research ·Berbel J.R. Sluijter,Mari F.C.M. van den Hout,Bas D. Koster,Paul A.M. van Leeuwen,Famke L. Schneiders,Rieneke van de Ven,Barbara G. Molenkamp,Saskia Vosslamber,Cornelis L. Verweij,M. Petrousjka van den Tol,Alfons J.M. van den Eertwegh,Rik J. Scheper,Tanja D. de Gruijl	2015	50
17	Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma Human Vaccines & Immunotherapeutics ·Jelle J. Lindenberg,Rieneke van de Ven,Dinja Oosterhoff,Claudia C. Sombroek,Sinéad M. Lougheed,Anita G.M. Stam,Hans J. P. M. Koenen,Alfons J.M. van den Eertwegh,Rik J. Scheper,Tanja D. de Gruijl	2014	4
18	Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition OncoImmunology ·Dinja Oosterhoff,Sinéad M. Lougheed,Rieneke van de Ven,Jelle J. Lindenberg,Hester van Cruijsen,Lotte Hiddingh,Jan Kroon,Alfons J.M. van den Eertwegh,Basav N. Hangalapura,Rik J. Scheper,Tanja D. de Gruijl	2012	50
19	High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model Cancer Immunology Immunotherapy ·Rieneke van de Ven,Sue Ellen Verbrugge,Anneke W. Reurs,Hetty J. Bontkes,Erik Hooijberg,Gerrit Jansen,Rik J. Scheper,George L. Scheffer,Tanja D. de Gruijl	2011	6
20	Dendritic Cells Require Multidrug Resistance Protein 1 (ABCC1) Transporter Activity for Differentiation The Journal of Immunology ·Rieneke van de Ven,Mariska C. de Jong,Anneke W. Reurs,A. Schoonderwoerd,Gerrit Jansen,Jan Hendrik Hooijberg,George L. Scheffer,Tanja D. de Gruijl,Rik J. Scheper	2006	55

About Rieneke van de Ven

Rieneke van de Ven is a scholar working on Immunology, Oncology and Otorhinolaryngology, having authored 61 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (40 papers), Cancer Immunotherapy and Biomarkers (24 papers), Immune Cell Function and Interaction (18 papers), CAR-T cell therapy research (13 papers), T-cell and B-cell Immunology (11 papers), Virus-based gene therapy research (7 papers), Head and Neck Cancer Studies (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Immunology (876 citations), Oncology (770 citations) and Cancer Research (90 citations). Rieneke van de Ven has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Tanja D. de Gruijl, Rik J. Scheper, George L. Scheffer, Jelle J. Lindenberg, Gerrit Jansen, Dinja Oosterhoff, Yvette van Kooyk, Dorian A. Stolk, Marieke F. Fransen and Alfons J.M. van den Eertwegh. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact